Tag Archives: Available

Freya Velanders New Book, Flying into the Night, Is Now Available for the Holidays


Fort Myers, Fla. (PRWEB) December 17, 2014

Recognized as a top professional in writing and motivational speaking, Freya Velander promotes women in professional aviation with her page-turner book and how-to speeches.

“Flying into the Night” (published by Lulu Publishing Services) grants readers an inside look at the life of a commercial airline pilot and the risk and danger of covert operations, mixed with the romantic world of jet pilots and exotic places. The beautiful and experienced leading character, Eldora, causes the men in her field to reassess what they believe about women in the male-dominated world of professional aviation. Though most of her time is filled with excitement and fun, she encounters some bumps along the way—ones that will test her skills professionally, emotionally and as the headstrong woman she has grown to be.

Intrigue, betrayal and love – “Flying into the Night” has it all.

“I couldn’t put this book down,” said user ~p~ in an Amazon review. “When I had to, I spent my time thinking about it & how I could get back to it! What an interesting, smart, brave and witty woman this Eldora is!”

“Freya Velandar, you need to write a sequel,” said TravelProf, another Amazon reviewer. “I read it on the plane on my way to Europe and it quickly became the shared book-of-choice for my friends as well. Sorry Freya! Should have made them all buy their own copies!”

Learn more about Freya’s book, and where you can purchase a copy, at http://www.FlyingintotheNight.com.

About the Author:

Freya Velander, of Norse descent, grew up on the beaches of Southern California. A feminine tomboy, she rode dirt bikes before she was old enough to drive cars. Racing cars became her next passion and then flying planes. She has been a corporate captain, a regional captain, and a flight officer at a major airline. She now lives with her husband in Southwestern Florida.

For more information about Freya, visit http://www.FreyaVelander.com and http://www.linkedin.com/pub/freya-velander/60/975/183.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.







United States Chronic Pain Industry 2014 Trends and 2019 Opportunities Now Available at MarketReportsOnline.com


Dallas, Texas (PRWEB) December 02, 2014

The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage

    Oxycodone
    Hydrocodone
    Morphine
    Hydromorphone
    Fentanyl
    Dihydrocodeine
    Methadone

Company Coverage

    Zogenix Inc.
    Egalet Corporation
    NektarTheropeutics

Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:

List of Tables and Figures

Table 1: Types of Acute and Chronic pain

Table 2: WHO Guidelines for Pain Therapy

Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)

Figure 2: US Opioid Sales in Chronic Pain Therapy Market – Forecast: 2014F-2019F (US$ B)

Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)

Figure 4: Oxycodone Market: Share of Leading Players (2027)

Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)

Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)

Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)

Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 10: US Long- Acting Morphine Market: 2014

Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)

Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)

Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)

Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)

Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)

Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)

Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:

MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the medical devices market, MarketReportsOnline.com offers research studies on pharmaceuticals, chemicals, agriculture, environment, biotechnology, public sector, retail, food and beverages, energy and power, semiconductor and electronics, advanced materials, banking and financial services, mining & utilities, consumer goods, agriculture, travel & hospitality, healthcare and much more.